|Articles|March 3, 2008

Pediatric indication granted to Nexium

Esomeprazole approved for children.

AstraZeneca has received Nexium) for use in children ages one to 11 years for the short-term treatment of gastrointestinal reflux disease (GERD). Both the delayed-release capsule and the liquid formulations have been approved for the new indication. Approved dosing of the proton pump inhibitor is 10 mg to 20 mg per day for children one to 11 years of age and a 20- to 40-mg daily dose for adolescents 12 to 17 years old.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

On-Demand Webinar

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

1.5 Credits / Cardiology

On-Demand Webinar

From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization

1.5 Credits / Cardiology

Pediatric indication granted to Nexium

Related Content

ACOG Releases Maternal Immunization Schedule, Differing From Previous CDC Schedule

Payers, Health Systems, and Pharmacies Partner to Fill SDOH-Related Gaps

Payer Preference Shifts Toward Unbundled, Transparent PBM Models

Helping Patients Find the Right OTC Relief for Seasonal Allergic Rhinitis

NCPDP Standards Advance Pharmacy Interoperability, AI, and Drug Access

Latest CME

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization

Mastering Hyperlipidemia Management: Enhancing Adherence and Expanding Nonstatin Therapy Options

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Beyond the Prescription: Tackling Social Isolation for Better Health

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education

Evaluating the Role of Pharmacists in Utilizing Potassium-Competitive Acid Blockers for Acid Peptic Disorders

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

Oncology Pharmacists Connect 2026

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacy Technician Credit)

Iron Deficiency Anemia Treatment Considerations in Women’s Health

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Expanding the Role of Long-Acting Injectables in Optimizing Schizophrenia Management

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Shifting Perspectives in Treatment-Resistant Depression: Novel Therapies and Patient-Centered Care

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Trending on Drug Topics

Hydrogel-Based Platforms for Chronic Wounds Help Address Infection

Some Providers Prescribe Unapproved Retatrutide for Weight Loss at Alarming Rate

Payer Preference Shifts Toward Unbundled, Transparent PBM Models

ACOG Releases Maternal Immunization Schedule, Differing From Previous CDC Schedule

FDA Approves Lebrikizumab for 8 Week Maintenance of Atopic Dermatitis